Paraoxonase 1 and HDL maturation.

Area of Science:

• Biochemistry
• Cardiovascular Science
• Lipid Metabolism

Background:

• Low paraoxonase 1 (PON1) activity is linked to increased cardiovascular events.
• The interaction between myeloperoxidase (MPO), apolipoprotein A-I (apoA-I), and PON1 on HDL is crucial in atherogenesis.
• Limited knowledge exists regarding PON1's integration into HDL and its fate during intravascular HDL remodeling.

Purpose of the Study:

• To investigate the integration and functional kinetics of PON1 within distinct HDL subclasses.
• To understand PON1's role in HDL remodeling and its interactions with other HDL components.
• To develop methods for assessing PON1 activity in HDL subclasses for potential clinical application.

Main Methods:

• Development of a novel method to assess PON1 activity in individual HDL subclasses.
• Ex vivo HDL maturation studies to track PON1 activation and flux.
• Inhibition studies using CETP and LCAT inhibitors to block PON1 activation and flux.
• Analysis of apo-lipoprotein and lipid shifts across various lipoprotein particles.

Main Results:

• PON1 is present across the HDL particle range, with preferential localization in HDL3.
• Ex vivo HDL maturation leads to PON1 activation and flux to smaller/larger HDL, VLDL, and sdLDL particles.
• ApoE, apoA-I, and apoA-II also exhibit particle size shifts during HDL maturation.
• CETP and LCAT inhibitors block PON1 activation and its flux across HDL particles.

Conclusions:

• PON1 plays a dynamic role in HDL remodeling, influencing particle composition and function.
• Understanding PON1's interactions within the complex HDL system is key to elucidating its atheroprotective mechanisms.
• Further kinetic studies in both fasting and post-prandial states are essential for a comprehensive understanding of HDL-PON1 function in circulation.